HBAN vs NVCR · P/E 13, rev $1.56B vs rev $655.4M
Huntington Bancshares Incorporated (HBAN) versus Novocure Ltd (NVCR) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Novocure Ltd (NVCR) is a medical devices company listed on US.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Latest reported NVCR revenue for 2025-12-31 was $655.4M. Net income was -$136.2M. NVCR currently screens at market cap $1.99B.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. NVCR currently screens at market cap $1.99B.
Not investment advice. Open the HBAN and NVCR stock pages for the full models.
Not investment advice.